MLPOX
Price
$9.75
Change
+$0.04 (+0.41%)
Updated
Jan 17 closing price
Net Assets
1.11B
SAIEX
Price
$11.11
Change
+$0.07 (+0.63%)
Updated
Jan 17 closing price
Net Assets
210.42M
Ad is loading...

MLPOX vs SAIEX

Header iconMLPOX vs SAIEX Comparison
Open Charts MLPOX vs SAIEXBanner chart's image
Invesco SteelPath MLP Alpha Y
Price$9.75
Change+$0.04 (+0.41%)
VolumeN/A
Net Assets1.11B
Spirit of America Energy Institutional
Price$11.11
Change+$0.07 (+0.63%)
VolumeN/A
Net Assets210.42M
MLPOX vs SAIEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MLPOX vs. SAIEX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLPOX is a Buy and SAIEX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
MLPOX has more cash in the bank: 1.11B vs. SAIEX (210M). SAIEX pays higher dividends than MLPOX: SAIEX (16.06) vs MLPOX (4.87). MLPOX was incepted earlier than SAIEX: MLPOX (15 years) vs SAIEX (5 years). MLPOX is a more actively managed with annual turnover of: 32.00 vs. SAIEX (15.00). MLPOX has a lower initial minimum investment than SAIEX: MLPOX (1000) vs SAIEX (100000). MLPOX annual gain was more profitable for investors over the last year : 53.21 vs. SAIEX (34.34).
MLPOXSAIEXMLPOX / SAIEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years5 years-
Gain YTD7.22110.00072%
Front LoadN/AN/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets1.11B210M530%
Annual Yield % from dividends4.8716.0630%
Returns for 1 year53.2134.34155%
Returns for 3 years114.3777.32148%
Returns for 5 years132.02N/A-
Returns for 10 years56.06N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FINV7.020.04
+0.57%
FinVolution Group
GRFS7.270.03
+0.41%
Grifols SA
INUV0.45N/A
+0.25%
Inuvo
AJG294.82-0.97
-0.33%
Arthur J Gallagher & Co
TRVI3.76-0.02
-0.53%
Trevi Therapeutics